According to Bloomberg, the damages award leveled against Takeda Pharmaceutical Co. and Eli Lilly & Co. is the seventh-largest in U.S. history.
The Food and Drug Administration has warned that using Actos (also known as pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. The FDA also acknowledged that doctors in France have suspended the use of pioglitazone, the active ingredient in Actos, and Germany has recommended doctors not prescribe it to new patients.
The National Cancer Institute estimates that there will be 74,690 new cases of bladder cancer in 2014, and 15,580 Americans will die from the disease. Treatment for bladder cancer can include surgery (which may involve removing the entire bladder), chemotherapy and biological and radiation therapy.
Bladder cancer can be a painful, difficult and even deadly disease, and you may be at particular risk if you have taken Actos. You may also be worried about what would happen to your job, your house, your family and your quality of life if you must fight this disease. At the McGartland Law Firm, we focus our practice on representing plaintiffs involved in both traditional personal injury and wrongful death litigation, aviation, nursing home abuse, trucking and construction accidents as well as mass tort litigation involving pharmaceutical products and defective medical devices.
The McGartland Law Firm represents individuals who have been injured by others. We represent people. If you have taken Actos, contact us now to start your free case review.
Toll Free: 866.832.9300